Description

1,4,9-Triazaspiro[5.5]Undecane, 4-[3-(3,5-Dimethoxyphenyl)-1,2,4-Oxadiazol-5-Yl]-1-Methyl-9-(2-Methyl-4-Pyridinyl)- is a high-purity, advanced pharmaceutical intermediate featuring a complex spirocyclic and heterocyclic architecture. This compound is of significant value for medicinal chemistry research and development, serving as a critical building block for novel therapeutic agents. It is primarily targeted at pharmaceutical R&D organizations and fine chemical manufacturers engaged in the synthesis of innovative drug candidates, particularly in areas like kinase inhibitors or central nervous system (CNS) modulators.

Application

• Pharmaceutical Intermediate: A key precursor in the multi-step synthesis of potential active pharmaceutical ingredients (APIs) for clinical research.
• Medicinal Chemistry Research: Used as a sophisticated scaffold for structure-activity relationship (SAR) studies and lead optimization in drug discovery programs.
• Kinase Inhibitor Development: The structural motifs suggest potential application in the design and synthesis of novel kinase inhibitor candidates for oncology and other therapeutic areas.
• Chemical Biology Probes: Serves as a core structure for developing specialized molecular probes to study biological pathways and target validation.
• Custom Synthesis & Contract Manufacturing: Supplied to CDMOs (Contract Development and Manufacturing Organizations) for custom synthesis projects requiring high-complexity intermediates.
• Academic Research: Utilized in university and institutional labs for advanced studies in organic synthesis methodology and heterocyclic chemistry.

Basic Information

Product Name	1,4,9-Triazaspiro[5.5]Undecane, 4-[3-(3,5-Dimethoxyphenyl)-1,2,4-Oxadiazol-5-Yl]-1-Methyl-9-(2-Methyl-4-Pyridinyl)-
CAS No.	2387510-80-5
Molecular Formula	C24H28N6O3
Molecular Weight	448.52 g/mol
Synonyms	4-[3-(3,5-Dimethoxyphenyl)-1,2,4-oxadiazol-5-yl]-1-methyl-9-(2-methylpyridin-4-yl)-1,4,9-triazaspiro[5.5]undecane; 1-Methyl-4-[3-(3,5-dimethoxyphenyl)-1,2,4-oxadiazol-5-yl]-9-(2-methyl-4-pyridinyl)-1,4,9-triazaspiro[5.5]undecane; CAS 2387510-80-5; 1,4,9-Triazaspiro[5.5]undecane derivative; Spirocyclic triaza compound; Oxadiazole-pyridine intermediate; Advanced heterocyclic building block.
EINECS	Contact for details

Quality Control

This high-value intermediate is produced under strict quality control protocols to ensure batch-to-batch consistency and purity suitable for research and development. Our quality system includes comprehensive analytical characterization using techniques such as HPLC, NMR, and MS. A detailed Certificate of Analysis (COA) is provided with each batch, confirming identity, purity, and impurity profile. We support our clients' regulatory needs with documentation traceability.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry place at a controlled room temperature (typically 15-25°C). This compound is hygroscopic (moisture-sensitive) and should be handled under dry conditions to prevent degradation. For long-term storage, consider desiccants or an inert atmosphere.

Specification

Item	Specification
Appearance	White to off-white solid
Identification (IR)	Conforms to structure
Identification (HPLC)	Conforms to reference
Purity (HPLC)	≥ 97.0%
Related Substances (HPLC)	Total impurities ≤ 3.0%
Water Content (KF)	≤ 1.0%
Residue on Ignition	≤ 0.5%

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.